ENST00000521599.5:c.-210+43372T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000521599.5(NCALD):​c.-210+43372T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.178 in 152,224 control chromosomes in the GnomAD database, including 2,908 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.18 ( 2908 hom., cov: 32)

Consequence

NCALD
ENST00000521599.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.961

Publications

6 publications found
Variant links:
Genes affected
NCALD (HGNC:7655): (neurocalcin delta) This gene encodes a member of the neuronal calcium sensor (NCS) family of calcium-binding proteins. The protein contains an N-terminal myristoylation signal and four EF-hand calcium binding loops. The protein is cytosolic at resting calcium levels; however, elevated intracellular calcium levels induce a conformational change that exposes the myristoyl group, resulting in protein association with membranes and partial co-localization with the perinuclear trans-golgi network. The protein is thought to be a regulator of G protein-coupled receptor signal transduction. Several alternatively spliced variants of this gene have been determined, all of which encode the same protein; additional variants may exist but their biological validity has not been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000521599.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.293 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000521599.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NCALD
NM_001040624.2
c.-297+43372T>C
intron
N/ANP_001035714.1P61601
NCALD
NM_001040625.2
c.-210+43372T>C
intron
N/ANP_001035715.1P61601
NCALD
NM_001040626.2
c.-210+43372T>C
intron
N/ANP_001035716.1B2RB70

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NCALD
ENST00000521599.5
TSL:1
c.-210+43372T>C
intron
N/AENSP00000428105.1P61601
NCALD
ENST00000311028.4
TSL:5
c.-210+43372T>C
intron
N/AENSP00000310587.3P61601
NCALD
ENST00000395923.5
TSL:5
c.-123+43705T>C
intron
N/AENSP00000379256.1P61601

Frequencies

GnomAD3 genomes
AF:
0.178
AC:
27070
AN:
152104
Hom.:
2908
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.297
Gnomad AMI
AF:
0.101
Gnomad AMR
AF:
0.145
Gnomad ASJ
AF:
0.107
Gnomad EAS
AF:
0.128
Gnomad SAS
AF:
0.162
Gnomad FIN
AF:
0.121
Gnomad MID
AF:
0.139
Gnomad NFE
AF:
0.132
Gnomad OTH
AF:
0.153
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.178
AC:
27079
AN:
152224
Hom.:
2908
Cov.:
32
AF XY:
0.174
AC XY:
12961
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.297
AC:
12329
AN:
41490
American (AMR)
AF:
0.144
AC:
2208
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.107
AC:
372
AN:
3470
East Asian (EAS)
AF:
0.128
AC:
662
AN:
5182
South Asian (SAS)
AF:
0.162
AC:
781
AN:
4826
European-Finnish (FIN)
AF:
0.121
AC:
1288
AN:
10624
Middle Eastern (MID)
AF:
0.143
AC:
42
AN:
294
European-Non Finnish (NFE)
AF:
0.132
AC:
8983
AN:
68020
Other (OTH)
AF:
0.153
AC:
322
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1141
2281
3422
4562
5703
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
288
576
864
1152
1440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.142
Hom.:
7357
Bravo
AF:
0.182
Asia WGS
AF:
0.171
AC:
592
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.28
DANN
Benign
0.54
PhyloP100
-0.96
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs7830150;
hg19: chr8-103093093;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.